NASDAQ · ATNI

ATN International, Inc.

$23.69 +$0.24 (+1.02%) 1D After hours
Charting by TradingView

Key Metrics

$360.68M
Market cap
—
P/E · TTM
$730.90M
Revenue · TTM
−$6.32M
Net income
EPS · TTM $-0.42
Dividend yield 4.5%
Free cash flow $37.60M
Beta · 1Y 0.40
EBITDA · TTM $111.54M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 5
    The stock moved -16.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 5
  • Feb 12
    The stock moved +12.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$360.68M
Enterprise value$821.61M
Shares outstanding15.4M
52-wk range$13.86 – $30.45
Avg volume · 20D60.3K
Net cash −$460.93M
Book value / share$28.66
IndustryTelephone Communications (No Radiotelephone)
ExchangeNASDAQ
About ATN International, Inc.
IPO dateNov 1, 1991
Employees2100

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.49
P/FCF9.59
EV/EBITDA7.37
EV/Sales1.12
Graham №—

Profitability

Gross —
Operating -2.5%
Net -0.9%
FCF 5.1%
ROE / ROIC -1.4% · -1.7%

Financial Health

Current ratio1.21
Quick ratio—
Debt / equity1.32
Debt / EBITDA 5.11
Net cash −$460.93M
Working capital$58.23M

Cash Flow · TTM

Operating CF $127.81M
Capex −$90.21M
Free cash flow $37.60M
Buybacks —
Dividends paid $16.24M
Shareholder yield 4.5%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

0.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings